Abstract
The Micra Transcatheter Pacing System (TPS) (Medtronic Inc, Minneapolis) is the first and only leadless pacemaker approved for use in the U.S. We ought to assess post marketing adverse events related to the Micra devices using the manufacturer and user facility device experience (MAUDE) database.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
